Category: health
Our mission is to provide health care tips empowering, evidence-based information that you can use to help yourself and your loved ones. Our health blogs help you help yourself by offering guidance and encouragement. By following our blogs you will start feeling better. We aim to provide articles that give the audience better information that can improve their lives. Our blogs cover topics such as health, fitness and their supplements. Also, it focuses on the essential things you need to know to understand the problem you’re facing, make informed decisions, and take positive steps. We deliver our readers a better online experience. Read on!
Beta Blockers – A discovery that transformed cardiac disease management!
[ad_1] Cardiovascular diseases (CVDs), one of the world’s leading causes of death, claim as many as 17.9 million lives each year globally. According to a study by the Indian Council of Medical Research and Registrar General of India, India accounts for approximately 60% of the global burden of heart disease. Additionally, the study highlights a ...
India emerging as a hub for clinical trials, says Parexel
[ad_1] Parexel, one of the world’s largest clinical research organisations (CROs), sees India emerging as a favourable destination to conduct clinical trials as global pharmaceutical and biotech companies make a beeline to test their potential drugs on Indian patients, a top executive of the company said. “In the past, if they wanted to do clinical ...
Cough Syrup: India probes bribery claim in toxic syrup tests
[ad_1] Indian authorities have launched an inquiry into an allegation that a local pharmaceutical regulator, in return for a bribe, helped switch samples of cough syrups that the World Health Organization (WHO) had linked to the deaths of children in Gambia before the samples were tested at an Indian laboratory, according to two government officials ...
Diabetes drug metformin may reduce risk of long Covid: Study
[ad_1] A new study suggests that taking the diabetes drug metformin after testing positive for Covid-19 may reduce the risk of developing long Covid by 40%. The US study published in the Lancet found that metformin prevented over 40% of cases of long Covid in the trial. However, further studies are needed to determine the ...
zydus: Zydus starts trial to generate data on effect of Saroglitazar Mg in NAFLD patients
[ad_1] NEW DELHI: Zydus Lifesciences on Friday said it has commenced Phase IV real world data registry trial to ascertain the benefits of Saroglitazar Magnesium in non-alcoholic fatty liver disease (NAFLD) patients with comorbidities. The “Phase IV EVIDENCES- XI” trial will enrol around 1,500 male and female NAFLD patients with comorbidities (either obesity, type 2 ...
Lancet survey: Over 11% Indians diabetic, 36% have hypertension: Lancet survey shows
[ad_1] NEW DELHI: The prevalence of diabetes in India is 11.4 per cent, while 35.5 per cent and 15.3 per cent of people suffer from hypertension and prediabetes respectively, according to the findings of a nationwide survey published in The Lancet Diabetes & Endocrinology journal. The largest epidemiological study on diabetes and non-communicable diseases (NCD) ...
india: Now, infertility treatment for employees gets India Inc cover
[ad_1] Infertility treatment – once a hushed-up subject – is now making its way into corporate insurance and benefits programmes, as India Inc looks to create inclusive and supportive workplaces. Recognising the importance of reproductive health and family planning support, a clutch of companies like Accenture, Cognizant, Procter & Gamble, Salesforce and WeWork are making ...
bayer pharma: Bayer steps up India R&D, clinical trials
[ad_1] Bayer Pharma is not only seeing India as potential high growth market but also as a hub for innovation, R&D and potential collaborations, top executives of the company told ET. “Our strategy for India in pharmaceuticals is to continue to make significant investments, we believe that India is a growing market with a growing ...
Nirma: Sekhmet, Nirma in fray for Glenmark’s API business
[ad_1] Sekhmet Pharmaventures is competing with Ahmedabad-based Nirma Group to acquire Glenmark Life Sciences (GLS), an 82.85% subsidiary of Glenmark Pharmaceuticals Ltd (GPL), as pharmacist promoter Glenn Saldanha looks to deleverage the balance sheet. Sekhmet is an active pharma ingredient (API) platform backed by private equity groups PAG, CX Partners and Samara Capital. GLS is ...
View: India needs to restore faith in the ‘World’s Pharmacy’
[ad_1] Indians have long been proud of their pharmaceutical sector. It’s a big exports earner in a country that can’t have too many. It boasts a number of well-regarded, profitable companies. And its exports to other developing countries allow us to think of ourselves as benefactors, and therefore leaders, of the Global South. Our success ...